Contact a Lawyer Now
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 20, 2019 to file lead plaintiff applications in a securities class action lawsuit against Teva Pharmaceutical Industries Limited (NYSE: TEVA).
Teva Pharmaceutical and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On May 10, 2019, an antitrust lawsuit against the Company was filed by an alliance of 44 state Attorneys General highlighting facts about its role as a “consistent participant” in a generic drug price-fixing conspiracy involving price increases for more than 110 generic drugs.
On this news, the price of Teva Pharmaceutical’s ADS plummeted by nearly 15%.
If you purchased ADS of Teva Pharmaceutical and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (firstname.lastname@example.org), or fill out the form on this page.
The case is Employees’ Retirement System of The City of St. Petersburg, Florida v. Teva Pharmaceutical, 19-cv-2711. Click here to read the case complaint.